MSH|^~\&|LAB|SMH|||202002120918||ORU^R01|4166246|D|2.3|||AL|NE
PID|1||SM00044281|RC6243|LABTEST^ACADEMIC^||20180321|M||||||||||SM005226/18|9876209312
OBR|1|39282^LAB|00029636^1202:C00010R^LAB^120220:C10^39282|499.0052^QCOWCARM2^QC ONE WORLD CARDIAC MARKERS 2^^^||202002120918|202002120918|||||||202002120918||||||||||LAB|F||||
OBX|1|ST|500.5650^BNP R^B Type Natriuretic Peptide^^30934-4^30934-4|1|55^^Y|pg/mL|0-100|N||A^S|F|||202002120918
NTE|1||BNP Interpretive Guidelines:
NTE|2||< 100     pg/mL  Does not support CHF
NTE|3||100 - 250 pg/mL  Borderline zone CHF
NTE|4||250 - 400 pg/mL  Supports CHF
NTE|5||> 400     pg/mL  Strongly supports CHF
NTE|6||Contact designated speciality Pathologist if required.
OBX|2|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|5.0^^Y|mg/L|<7.5|N||A^S|F|||202002120918
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.